Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/07/1997US5674505 Administering tin chloride mixed with lotions, cream and shampoo to treat skin disorders and dandruff
10/07/1997US5674482 Having properties which mimic pharmacological activity of naturally occurring polymers including glycosaminoglycans, peptides and polynucleic acids
10/07/1997US5674472 Drug delivery
10/07/1997US5674471 Aerosol formulations containing P134a and salbutamol
10/07/1997US5674467 Used in nmr diagnosis, radiodiagnosis or radiotherapy
10/07/1997CA2158482C Ucf1 compounds, derivatives thereof and processes for their preparation
10/07/1997CA2054967C Enhanced flavors using menthone ketals
10/07/1997CA2030166C Pradimicin derivatives
10/07/1997CA2015730C Esters of phenylalkanoic acid
10/07/1997CA2009637C Substituted-1,3-oxathiolanes with antiviral properties
10/07/1997CA2004154C 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl 1,2,4-thiadiazoles, oxadiazoles and triazoles as anti-inflammatory agents
10/07/1997CA1339488C De-n-acetyl-syalic acid and their applications as modifiers of cell physiology
10/04/1997CA2201434A1 Novel pyrimido[1,2-a¦indoles
10/02/1997WO1997035998A1 Methods of modulating melanin synthesis
10/02/1997WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997WO1997035990A2 Histone deacetylases, and uses related thereto
10/02/1997WO1997035989A2 Cyclic nucleotide phosphodiesterase
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997WO1997035969A2 Peptide ligands of the urokinase receptor
10/02/1997WO1997035887A1 Precursors of catalytic antibodies
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035883A1 Method and apparatus for preparing an acellular red blood cell substitute
10/02/1997WO1997035877A1 Antibiotic peptides from bovine milk
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
10/02/1997WO1997035862A1 Azaspiroderivatives
10/02/1997WO1997035861A1 Azaspiro derivatives
10/02/1997WO1997035858A1 4-[(THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING α2-ADRENOCEPTOR AGONISTIC ACTIVITY
10/02/1997WO1997035857A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity
10/02/1997WO1997035856A1 Novel treatment for cns injuries
10/02/1997WO1997035855A1 Novel treatment for cns injuries
10/02/1997WO1997035854A1 Novel phenanthridines substituted in the 6 position
10/02/1997WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997WO1997035849A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997WO1997035846A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
10/02/1997WO1997035843A1 Lymph-absorbable imidazole derivatives
10/02/1997WO1997035627A1 Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring
10/02/1997WO1997035620A1 Formulations of ob protein
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035617A1 Use of a texaphyrin in photodynamic therapy of pigment-related lesions
10/02/1997WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997WO1997035613A1 Method of producing immunogenic products and vaccines
10/02/1997WO1997035611A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997WO1997035608A1 Diabetes treatment
10/02/1997WO1997035607A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
10/02/1997WO1997035606A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders
10/02/1997WO1997035602A1 Use of vasopressin receptor antagonist for regulation of acth release
10/02/1997WO1997035601A1 TREATMENT OF CYSTIC DISEASE WITH TNF-$g(a)
10/02/1997WO1997035597A1 Acne treatment
10/02/1997WO1997035593A1 Polyethylene glycol esters of polyunsaturated fatty acids
10/02/1997WO1997035592A1 Iib/iiia antagonists co-administered with aspirin and/or heparin
10/02/1997WO1997035591A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/02/1997WO1997035590A1 10-aza-9-deoxo-11-deoxy-erythromycin a and derivatives combined with sulfisoxazole
10/02/1997WO1997035588A1 Novel uses of phospholipase c inhibitors
10/02/1997WO1997035587A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
10/02/1997WO1997035586A1 Method for treating pain
10/02/1997WO1997035585A1 Anesthetic method
10/02/1997WO1997035584A1 Method for treating pain
10/02/1997WO1997035583A1 Method for treating pain
10/02/1997WO1997035582A1 Method for treating migraine pain
10/02/1997WO1997035581A1 Interleukin-6 production inhibitor
10/02/1997WO1997035580A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
10/02/1997WO1997035579A1 A method for inhibiting clot formation
10/02/1997WO1997035578A1 Tetrahydro-beta-carboline compounds
10/02/1997WO1997035577A1 Remedy for spinal injury
10/02/1997WO1997035576A1 Use of isoniazid for the treatment of hyperlipoproteinemia
10/02/1997WO1997035575A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/02/1997WO1997035574A1 Composition containing milnacipran and idazoxan for use as a combined pharmaceutical preparation
10/02/1997WO1997035573A2 NSAIDs IN THE TREATMENT OF PRURITUS
10/02/1997WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997WO1997035571A1 Benzothiophenes, formulations containing same, and methods
10/02/1997WO1997035570A1 Use of unsaturated monocarboxylic acids against superinfections
10/02/1997WO1997035569A1 Use of heme oxygenase inhibitors to treat cancer
10/02/1997WO1997035568A2 Diclofenac/gamma-cyclodextrin inclusion compounds
10/02/1997WO1997035567A1 Pla2 inhibitors of angiogenesis
10/02/1997WO1997035566A1 Inhibition of nitric oxide formation in acute and chronic inflammation
10/02/1997WO1997035562A1 Polysaccharide microspheres for the pulmonary delivery of drugs
10/02/1997WO1997035557A1 External skin-care composition
10/02/1997WO1997035556A1 Use of an extract of at least one iridaceous plant for treating wrinkles
10/02/1997WO1997035539A2 Arylamino fused pyridines and pyrimidines
10/02/1997WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997WO1997035491A1 Agent for increasing the production of/in breeding and production mammals
10/02/1997WO1997035480A1 Method of treating common cold or allergic rhinitis
10/02/1997WO1997035479A1 Methods of treating venomous bites and stings
10/02/1997WO1997035477A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/02/1997WO1997028825A3 Spermatogenesis control
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997WO1997024111A3 Novel hyaluronic acid receptors binding agents and the use thereof
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997WO1997019675A3 Complex cationic lipids
10/02/1997WO1997019673A3 Reduction of hair growth
10/02/1997WO1997013502A3 Prolonged release of gm-csf
10/02/1997DE19612966A1 Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren Animal cells and processes for replication of influenza viruses
10/02/1997DE19612807A1 Neue Benzaldehyd-Derivate aus Hericeum erinaceus New benzaldehyde derivatives from Hericeum erinaceus
10/02/1997DE19612805A1 Antifungische Peptide aus Scleroderma texense Texense antifungal peptides from Scleroderma
10/02/1997DE19612645A1 Dimethyl-substituierte Cyclohexandienderivate Dimethyl-substituted Cyclohexandienderivate
1 ... 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 6754 6755 6756 6757 6758 6759 6760 6761 6762 ... 7860